Stuff in ‘magic mushrooms’ could treat major depression

Two doses of the psychedelic substance psilocybin, given with supportive psychotherapy, produced rapid and large reductions in depressive symptoms in a small study of adults with major depression, researchers report. According to the study, most participants showed improvement and half of study participants achieved remission through the four-week follow-up. A compound found in so-called magic…

Hospital support staff face far higher COVID risk

Support staff and Black and Latinx hospital employees with and without patient care responsibilities have the highest risk for SARS-CoV-2 infection in health care settings, a new study shows. Researchers screened 3,904 employees and clinicians at a New Jersey hospital between late April and late June for the SARS-CoV-2 virus and for lgG-antibodies to the…

End-of-life care stats reveal racial gaps

Black Americans pursue more intensive treatments than white Americans in the last six months of life, researchers report. White people are also more likely to use hospice care, according to the new study. The intensive treatments Black patients are more likely to seek include mechanical ventilation, gastronomy tube insertion, hemodialysis, CPR, and multiple emergency room…

Mutations may have made SARS-CoV-2 more contagious

SARS-CoV-2, the virus that causes COVID-19, is accumulating genetic mutations, one of which may have made it more contagious, according to a study of more than 5,000 patients in Houston, Texas. “The virus continues to mutate as it rips through the world.” That mutation, called D614G, is located in the spike protein that pries open…